|
Insider Trading: VISICU INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of VISICU INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of VISICU INC since year 2005. Table 2 shows the detailed insider transactions of VISICU INC since 2005.
The reporting company's ticker symbol is EICU.
The reporting company's CIK number is 1166463.
The total value of stock buying since 2005 is $320,828.
The total value of stock sales is $20,346,303.
The total value of stock exercises is $107,196.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at VISICU INC (EICU) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at VISICU INC (EICU) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for VISICU INC (EICU).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2007-10 | 0 | 0 | 8,100 | 64,800 | 8,000 | 7,148 |
| 2007-09 | 0 | 0 | 18,000 | 144,000 | 8,000 | 7,150 |
| 2007-08 | 0 | 0 | 18,000 | 144,000 | 8,000 | 7,149 |
| 2007-07 | 0 | 0 | 18,000 | 164,906 | 8,000 | 7,150 |
| 2007-06 | 0 | 0 | 32,700 | 320,743 | 9,300 | 9,489 |
| 2007-05 | 0 | 0 | 36,300 | 339,183 | 9,700 | 10,210 |
| 2007-04 | 0 | 0 | 46,592 | 395,336 | 17,000 | 16,100 |
| 2007-03 | 0 | 0 | 1,224 | 9,792 | 0 | 0 |
| 2007-02 | 0 | 0 | 29,000 | 302,637 | 9,000 | 8,950 |
| 2007-01 | 0 | 0 | 39,200 | 408,879 | 9,000 | 8,950 |
| 2006-12 | 0 | 0 | 29,000 | 290,271 | 9,000 | 8,950 |
| 2006-11 | 10,000 | 92,828 | 1,736,000 | 17,761,756 | 29,000 | 15,950 |
| 2006-04 | 14,250 | 228,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for VISICU INC (EICU)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-10-12 | Estrada Vincent E (Sr VP and CFO) | Sale | 2,838 | 8.00 | 22,704 |
| 2007-10-12 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 2,838 | 1.80 | 5,108 |
| 2007-10-12 | Sample Frank T (Chairman and CEO) | Sale | 4,729 | 8.00 | 37,832 |
| 2007-10-12 | Sample Frank T (Chairman and CEO) | Option Exercise | 4,729 | .35 | 1,655 |
| 2007-10-08 | Sample Frank T (Chairman and CEO) | Sale | 171 | 8.00 | 1,368 |
| 2007-10-08 | Sample Frank T (Chairman and CEO) | Option Exercise | 171 | .35 | 59 |
| 2007-10-05 | Breslow Michael J (EVP Clinical R&D) | Sale | 100 | 8.00 | 800 |
| 2007-10-05 | Estrada Vincent E (Sr VP and CFO) | Sale | 162 | 8.00 | 1,296 |
| 2007-10-05 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 162 | 1.80 | 291 |
| 2007-10-05 | Sample Frank T (Chairman and CEO) | Sale | 100 | 8.00 | 800 |
| 2007-10-05 | Sample Frank T (Chairman and CEO) | Option Exercise | 100 | .35 | 35 |
| 2007-09-21 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,000 | 8.00 | 40,000 |
| 2007-09-21 | Rosenfeld Brian A (EVP and CMO) | Sale | 5,000 | 8.00 | 40,000 |
| 2007-09-21 | Estrada Vincent E (Sr VP and CFO) | Sale | 3,000 | 8.00 | 24,000 |
| 2007-09-21 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 3,000 | 1.80 | 5,400 |
| 2007-09-21 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 8.00 | 40,000 |
| 2007-09-21 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2007-08-07 | Breslow Michael J (EVP Clinical R&D) | Sale | 4,022 | 8.00 | 32,176 |
| 2007-08-07 | Rosenfeld Brian A (EVP and CMO) | Sale | 3,600 | 8.00 | 28,800 |
| 2007-08-07 | Estrada Vincent E (Sr VP and CFO) | Sale | 992 | 8.00 | 7,936 |
| 2007-08-07 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 992 | 1.80 | 1,785 |
| 2007-08-07 | Sample Frank T (Chairman and CEO) | Sale | 3,400 | 8.00 | 27,200 |
| 2007-08-07 | Sample Frank T (Chairman and CEO) | Option Exercise | 3,400 | .35 | 1,190 |
| 2007-08-06 | Breslow Michael J (EVP Clinical R&D) | Sale | 978 | 8.00 | 7,824 |
| 2007-08-06 | Rosenfeld Brian A (EVP and CMO) | Sale | 1,400 | 8.00 | 11,200 |
| 2007-08-06 | Estrada Vincent E (Sr VP and CFO) | Sale | 2,008 | 8.00 | 16,064 |
| 2007-08-06 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 2,008 | 1.80 | 3,614 |
| 2007-08-06 | Sample Frank T (Chairman and CEO) | Sale | 1,600 | 8.00 | 12,800 |
| 2007-08-06 | Sample Frank T (Chairman and CEO) | Option Exercise | 1,600 | .35 | 560 |
| 2007-07-05 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 9.24 | 46,212 |
| 2007-07-05 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2007-07-02 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,000 | 9.13 | 45,664 |
| 2007-07-02 | Rosenfeld Brian A (EVP and CMO) | Sale | 5,000 | 9.13 | 45,650 |
| 2007-07-02 | Estrada Vincent E (Sr VP and CFO) | Sale | 3,000 | 9.13 | 27,380 |
| 2007-07-02 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 3,000 | 1.80 | 5,400 |
| 2007-06-08 | Breslow Michael J (EVP Clinical R&D) | Sale | 3,250 | 10.00 | 32,500 |
| 2007-06-08 | Rosenfeld Brian A (EVP and CMO) | Sale | 3,350 | 10.00 | 33,500 |
| 2007-06-08 | Estrada Vincent E (Sr VP and CFO) | Sale | 31 | 10.00 | 310 |
| 2007-06-08 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 31 | 1.80 | 55 |
| 2007-06-06 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 9.64 | 48,175 |
| 2007-06-06 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2007-06-01 | Breslow Michael J (EVP Clinical R&D) | Sale | 8,450 | 9.79 | 82,756 |
| 2007-06-01 | Rosenfeld Brian A (EVP and CMO) | Sale | 8,350 | 9.79 | 81,732 |
| 2007-06-01 | Estrada Vincent E (Sr VP and CFO) | Sale | 4,269 | 9.78 | 41,770 |
| 2007-06-01 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 4,269 | 1.80 | 7,684 |
| 2007-05-31 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,700 | 10.00 | 57,000 |
| 2007-05-31 | Rosenfeld Brian A (EVP and CMO) | Sale | 5,043 | 10.00 | 50,430 |
| 2007-05-31 | Estrada Vincent E (Sr VP and CFO) | Sale | 700 | 10.00 | 7,000 |
| 2007-05-31 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 700 | 1.80 | 1,260 |
| 2007-05-30 | Breslow Michael J (EVP Clinical R&D) | Sale | 2,600 | 10.00 | 26,000 |
| 2007-05-30 | Rosenfeld Brian A (EVP and CMO) | Sale | 3,257 | 10.00 | 32,570 |
| 2007-05-30 | Estrada Vincent E (Sr VP and CFO) | Sale | 1,000 | 10.00 | 10,000 |
| 2007-05-30 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 1,000 | 1.80 | 1,800 |
| 2007-05-02 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 8.74 | 43,675 |
| 2007-05-02 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2007-05-01 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,000 | 8.63 | 43,150 |
| 2007-05-01 | Rosenfeld Brian A (EVP and CMO) | Sale | 5,000 | 8.68 | 43,384 |
| 2007-05-01 | Estrada Vincent E (Sr VP and CFO) | Sale | 3,000 | 8.66 | 25,974 |
| 2007-05-01 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 3,000 | 1.80 | 5,400 |
| 2007-04-30 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,000 | 10.06 | 50,300 |
| 2007-04-30 | Rosenfeld Brian A (EVP and CMO) | Sale | 5,000 | 10.06 | 50,300 |
| 2007-04-30 | Estrada Vincent E (Sr VP and CFO) | Sale | 1,000 | 10.00 | 10,000 |
| 2007-04-30 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 1,000 | 1.80 | 1,800 |
| 2007-04-20 | Breslow Michael J (EVP Clinical R&D) | Sale | 9,592 | 8.00 | 76,736 |
| 2007-04-20 | Rosenfeld Brian A (EVP and CMO) | Sale | 10,000 | 8.00 | 80,000 |
| 2007-04-20 | Estrada Vincent E (Sr VP and CFO) | Sale | 6,000 | 8.00 | 48,000 |
| 2007-04-20 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 6,000 | 1.80 | 10,800 |
| 2007-04-20 | Sample Frank T (Chairman and CEO) | Sale | 10,000 | 8.00 | 80,000 |
| 2007-04-20 | Sample Frank T (Chairman and CEO) | Option Exercise | 10,000 | .35 | 3,500 |
| 2007-03-23 | Breslow Michael J (EVP Clinical R&D) | Sale | 816 | 8.00 | 6,528 |
| 2007-02-07 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 10.88 | 54,413 |
| 2007-02-07 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2007-02-01 | Breslow Michael J (EVP Clinical R&D) | Sale | 10,000 | 10.34 | 103,409 |
| 2007-02-01 | Rosenfeld Brian A (EVP and CMO) | Sale | 10,000 | 10.35 | 103,475 |
| 2007-02-01 | Estrada Vincent E (Sr VP and CFO) | Sale | 4,000 | 10.34 | 41,340 |
| 2007-02-01 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 4,000 | 1.80 | 7,200 |
| 2007-01-03 | Breslow Michael J (EVP Clinical R&D) | Sale | 10,000 | 10.58 | 103,532 |
| 2007-01-03 | Rosenfeld Brian A (EVP and CMO) | Sale | 10,000 | 10.37 | 103,924 |
| 2007-01-03 | Estrada Vincent E (Sr VP and CFO) | Sale | 4,000 | 10.47 | 41,865 |
| 2007-01-03 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 4,000 | 1.80 | 7,200 |
| 2007-01-03 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 10.03 | 51,560 |
| 2007-01-03 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2006-12-06 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 10.04 | 50,221 |
| 2006-12-06 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2006-12-01 | Breslow Michael J (EVP Clinical R&D) | Sale | 10,000 | 10.00 | 100,000 |
| 2006-12-01 | Rosenfeld Brian A (EVP and CMO) | Sale | 10,000 | 10.00 | 100,050 |
| 2006-12-01 | Estrada Vincent E (Sr VP and CFO) | Sale | 4,000 | 10.00 | 40,000 |
| 2006-12-01 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 4,000 | 1.80 | 7,200 |
| 2006-11-30 | Tatum Lisa Skeete (10% Owner) | Sale | 387,000 | 10.04 | 3,885,600 |
| 2006-11-30 | Clarke John K (Director) | Sale | 387,000 | 10.04 | 3,885,600 |
| 2006-11-30 | Sample Frank T (Chairman and CEO) | Sale | 20,000 | 10.00 | 200,000 |
| 2006-11-30 | Sample Frank T (Chairman and CEO) | Option Exercise | 20,000 | .35 | 7,000 |
| 2006-11-28 | Bronfein Michael G (Director) | Purchase | 10,000 | 9.28 | 92,828 |
| 2006-11-16 | Tatum Lisa Skeete (10% Owner) | Sale | 31,500 | 10.04 | 316,305 |
| 2006-11-16 | Clarke John K (Director) | Sale | 31,500 | 10.04 | 316,394 |
| 2006-11-07 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,000 | 10.00 | 50,000 |
| 2006-11-07 | Rosenfeld Brian A (EVP and CMO) | Sale | 10,000 | 10.14 | 101,360 |
| 2006-11-07 | Estrada Vincent E (Sr VP and CFO) | Sale | 1,000 | 10.00 | 10,000 |
| 2006-11-07 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 1,000 | 1.80 | 1,800 |
| 2006-11-07 | Sterling Venture Partners Llc (10% Owner) | Sale | 425,000 | 10.44 | 4,436,763 |
| 2006-11-07 | Bronfein Michael G (Director) | Sale | 425,000 | 10.44 | 4,436,763 |
| 2006-11-03 | Breslow Michael J (EVP Clinical R&D) | Sale | 5,000 | 9.34 | 46,705 |
| 2006-11-01 | Estrada Vincent E (Sr VP and CFO) | Sale | 3,000 | 9.52 | 28,563 |
| 2006-11-01 | Estrada Vincent E (Sr VP and CFO) | Option Exercise | 3,000 | 1.80 | 5,400 |
| 2006-11-01 | Sample Frank T (Chairman and CEO) | Sale | 5,000 | 9.54 | 47,703 |
| 2006-11-01 | Sample Frank T (Chairman and CEO) | Option Exercise | 5,000 | .35 | 1,750 |
| 2006-04-05 | Hull Brandon H (10% Owner) | Purchase | 4,000 | 16.00 | 64,000 |
| 2006-04-05 | Oakey James A (Director) | Purchase | 3,000 | 16.00 | 48,000 |
| 2006-04-05 | Sabin Ralph C (Director) | Purchase | 2,250 | 16.00 | 36,000 |
| 2006-04-05 | Altman Stuart H (Director) | Purchase | 5,000 | 16.00 | 80,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of VISICU INC (symbol EICU,
CIK number 1166463) see
the Securities and Exchange Commission (SEC) website.
|
|
